122 results
8-K
EX-99.1
BTTX
Better Therapeutics Inc
11 Mar 24
Regulation FD Disclosure
9:01am
be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks
424B3
BTTX
Better Therapeutics Inc
10 Jan 24
Prospectus supplement
7:01am
. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions … to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future
8-K
EX-99.1
BTTX
Better Therapeutics Inc
8 Jan 24
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
4:42pm
and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been
8-K
EX-10.1
6e7ms
8 Jan 24
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
4:42pm
424B3
8vzcrxz4n62rnwcp 4ue
28 Dec 23
Prospectus supplement
9:23pm
8-K
jq4dr9xbz9
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:58pm
8-K
EX-10.1
t36v0
13 Dec 23
Entry into a Material Definitive Agreement
5:06pm
8-K
EX-99.1
4bup9ctz
9 Nov 23
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:03am
PRE 14A
afmvv x7ski58
6 Oct 23
Preliminary proxy
4:15pm